Lessons learned from an unsuccessful decentralized clinical trial in Oncology.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 39138304.
- Also identified by DOI 10.1038/s41746-024-01214-5 and PMC identifier 11322600.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Decentralized clinical trials have gained in popularity over the last years due to their advantages related to broadening recruitment strategies and resource saving possibilities. As more clinical trials adopt decentralized strategies, it is essential to share the knowledge about both successful and unsuccessful efforts in the research community. In the present commentary, we explore potential reasons that led to early termination of a decentralized clinical trial in Oncology.